Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immature and misleading

12.04.2012
Are modern molecular classification methods for breast carcinomas reasonable?

Austrian scientists challenge the clinical relevance of the term “basal-like” breast cancer subtype. Not all breast cancers are the same. Different types can mean different prognoses for the patient, and a different kind of treatment may be adequate. But how to classify tumors? Are molecular classification methods reliable?

Mohammad Ali Lavasani and Farid Moinfar from the Unit of Breast and Gynecologic Pathology at the Medical University of Graz, Austria give a critical review of the literature with focus on “basal-like” carcinoma.

The conventional clinicopathological parameters such as histologic grade, nuclear grade, tumor size, involvement of axillary lymph nodes, etc., all have been successfully correlated to prognosis of patients with breast carcinoma. Yet, the current prognostic and/or predictive factors have significant limitations in distinguishing breast cancer patients who could benefit from (neo)adjuvant chemotherapy from those who do not need any additional treatment.

Indeed, it has been suggested that almost 70% of patients with breast cancer receiving chemotherapy or antihormonal therapy would have survived without such treatments, as Lavasani and Moinfar state in their review.

With the introduction of complementary DNA (cDNA) and oligonucleotide microarrays in the 1990s, the increasing application of these high-throughput biotechnologies, and significant improvement in bioinformatic analyses a new era began: Genome-wide approaches were used to prognostify and predict outcome in patients with breast cancer. During the last 11 years, 5 molecular subtypes of breast carcinoma (luminal A, luminal B, Her2-positive, basal-like, and normal breast-like) have been characterized and intensively studied. As genomic research evolves, further subtypes of breast cancers into new “molecular entities” are expected to occur. For example, a new and rare breast cancer subtype, known as claudin-low, has been recently found.

“There is no doubt that global gene expression analyses using high-throughput biotechnologies have drastically improved our understanding of breast cancer as a heterogeneous disease”, say Lavasani and Moinfar. “The main question is, however, whether new molecular techniques such as gene expression profiling (or signature) should be regarded as the gold standard for identifying breast cancer subtypes.” When reviewing the literature, the two scientists discovered major problems with current molecular techniques and classification including poor definitions, lack of reproducibility, and lack of quality control. They conclude: “The current molecular approaches cannot be incorporated into routine clinical practice and treatment decision making as they are immature or even can be misleading.”

The “basal-like” breast cancer subtype represents one of the most popular breast cancer “entities”. However, the authors revealed some major problems and misconceptions with and about this subtype and denote the term “basal-like” as misleading. They come to the conclusion that there is no evidence that expression of basal-type cytokeratins in a given breast cancer, regardless of other established prognostic factors, does have any impact on clinical outcome. Lavasani and Moinfar are convinced that these so-called basal-like carcinomas do not reflect a single, biologically uniform group of breast cancers. Indeed, they show significant variations in their phenotypes, grades, immunoprofiles, and clinical outcomes. (Text by K. Maedefessel-Herrmann)

M. A. Lavasani and F. Moinfar, J. Biophotonics 5(4), 345-366 (2012); http://dx.doi.org/10.1002/jbio.201100097

Journal of Biophotonics publishes cutting edge research on interactions between light and biological material. The journal is highly interdisciplinary, covering research in the fields of life sciences, medicine, physics, chemistry, and enginieering. The scope extends from basic research to clinical applications. Connecting scientists who try to understand basic biological processes using light as a diagnostic and therapeutic tool, the journal offers a platform where the physicist communicates with the biologist and where the clinical practitioner learns about the latest tools for diagnosis of diseases. JBP offers fast publication times: down to 20 days from acceptance to publication. Latest Journal Impact Factor (2010): 4.240 (ISI Journal Citation Reports 2010)

Regina Hagen
Journal Publishing Manager | Editorial Physics Department
Wiley-VCH Verlag GmbH & Co. KGaA
Rotherstr. 21, 10245 Berlin, Germany
Fon: +49 (0) 30/ 47 03 13 21
Fax: +49 (0) 30/ 47 03 13 99
E-Mail: regina.hagen@wiley.com

Lavasani and F. Moinfar | Wiley-VCH
Further information:
http://dx.doi.org/10.1002/jbio.201100097
http://www.wiley.com

More articles from Life Sciences:

nachricht Modeling predicts blue whales' foraging behavior, aiding population management efforts
18.07.2019 | Oregon State University

nachricht Plant viruses may be reshaping our world
18.07.2019 | Arizona State University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-ever visualizations of electrical gating effects on electronic structure

Scientists have visualised the electronic structure in a microelectronic device for the first time, opening up opportunities for finely-tuned high performance electronic devices.

Physicists from the University of Warwick and the University of Washington have developed a technique to measure the energy and momentum of electrons in...

Im Focus: Megakaryocytes act as „bouncers“ restraining cell migration in the bone marrow

Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. The study was published in July in the Journal “Haematologica”.

Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The bone marrow produces all types of blood cells: red...

Im Focus: Artificial neural network resolves puzzles from condensed matter physics: Which is the perfect quantum theory?

For some phenomena in quantum many-body physics several competing theories exist. But which of them describes a quantum phenomenon best? A team of researchers from the Technical University of Munich (TUM) and Harvard University in the United States has now successfully deployed artificial neural networks for image analysis of quantum systems.

Is that a dog or a cat? Such a classification is a prime example of machine learning: artificial neural networks can be trained to analyze images by looking...

Im Focus: Extremely hard yet metallically conductive: Bayreuth researchers develop novel material with high-tech prospects

An international research group led by scientists from the University of Bayreuth has produced a previously unknown material: Rhenium nitride pernitride. Thanks to combining properties that were previously considered incompatible, it looks set to become highly attractive for technological applications. Indeed, it is a super-hard metallic conductor that can withstand extremely high pressures like a diamond. A process now developed in Bayreuth opens up the possibility of producing rhenium nitride pernitride and other technologically interesting materials in sufficiently large quantity for their properties characterisation. The new findings are presented in "Nature Communications".

The possibility of finding a compound that was metallically conductive, super-hard, and ultra-incompressible was long considered unlikely in science. It was...

Im Focus: Modelling leads to the optimum size for platinum fuel cell catalysts: Activity of fuel cell catalysts doubled

An interdisciplinary research team at the Technical University of Munich (TUM) has built platinum nanoparticles for catalysis in fuel cells: The new size-optimized catalysts are twice as good as the best process commercially available today.

Fuel cells may well replace batteries as the power source for electric cars. They consume hydrogen, a gas which could be produced for example using surplus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on UV LED Technologies & Applications – ICULTA 2020 | Call for Abstracts

24.06.2019 | Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

 
Latest News

A graphene superconductor that plays more than one tune

18.07.2019 | Physics and Astronomy

Plant viruses may be reshaping our world

18.07.2019 | Life Sciences

First-ever visualizations of electrical gating effects on electronic structure

18.07.2019 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>